P. S. Sillevis Smitt

T. Luider, J. Kros, P. S. Sillevis Smitt, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

M. J. van den Bent, T. Gorlia, P. Eilers, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Locoregional delivery of adenoviral vectors.

P. S. Sillevis Smitt, M. de Jong, B. de Leeuw, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The rate of false positive sequence matches of peptides profiled by MALDI MS and identified by MS/MS.

T. Luider, R. Lamers, P. S. Sillevis Smitt, 2008, Journal of proteome research.

Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy

M. J. van den Bent, P. S. Sillevis Smitt, W. van Putten, 2002, Journal of Neurology.

Sequencing and quantifying IgG fragments and antigen-binding regions by mass spectrometry.

R. V. van Klaveren, H. Hoogsteden, T. Luider, 2010, Journal of proteome research.

Identification of delta/notch‐like epidermal growth factor‐related receptor as the Tr antigen in paraneoplastic cerebellar degeneration

C. Hoogenraad, M. J. van den Bent, Jeroen A. A. Demmers, 2012, Annals of neurology.

The clinical spectrum of Caspr2 antibody–associated disease

J. Dalmau, P. S. Sillevis Smitt, F. Leypoldt, 2016, Neurology.

Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over time

M. J. van den Bent, P. S. Sillevis Smitt, J. Gratama, 2011, Journal of Neurology.

Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma

T. Luider, J. Kros, P. S. Sillevis Smitt, 2022, International journal of molecular sciences.

Resolution of EBV+ CNS lymphoma with appearance of CSF EBV‐specific T cells

M. J. van den Bent, P. S. Sillevis Smitt, J. Cornelissen, 2005, Annals of neurology.

The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review

M. J. van den Bent, P. French, P. S. Sillevis Smitt, 2022, Neuro-oncology advances.

The effects of analgesic prescription and patient adherence on pain in a dutch outpatient cancer population.

P. S. Sillevis Smitt, A. V. Van Gool, R. Enting, 2007, Journal of pain and symptom management.

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.

Andrew P. Stubbs, R. Vernhout, M. J. van den Bent, 2016, Cancer research.

Acute CNS white matter lesions in patients with inflammatory bowel disease

E. Kuipers, P. S. Sillevis Smitt, R. Hintzen, 2009, Inflammatory bowel diseases.

Evaluation of the new body fluid mode on the Sysmex XE-5000 for counting leukocytes and erythrocytes in cerebrospinal fluid and other body fluids

P. S. Sillevis Smitt, J. Lindemans, R. de Jonge, 2010, Clinical chemistry and laboratory medicine.

Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice

P. S. Sillevis Smitt, J. Posner, G. Manley, 1995, Neurology.

Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration in a Man with Adenocarcinoma of the Gastroesophageal Junction

P. S. Sillevis Smitt, J. V. van Lanschot, S. Lagarde, 2007, Digestive Surgery.

No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies

P. S. Sillevis Smitt, J. Gratama, H. Hooijkaas, 2007, Cancer Immunology, Immunotherapy.

An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes

M. Bent, P. S. Sillevis Smitt, J. Gratama, 2005, Journal of Neurology.

Pregnancy Zone Protein is Increased in the Alzheimer's Disease Brain and Associates with Senile Plaques.

P. Koudstaal, T. Luider, J. Kros, 2015, Journal of Alzheimer's disease : JAD.

Anti-Ri antibody positive opsoclonus-myoclonus in a male patient with breast carcinoma

J. Verschuuren, P. S. Sillevis Smitt, S. V. van Duinen, 2002, Journal of Neurology.

Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma

P. S. Sillevis Smitt, G. Stoter, W. Kruit, 2003, Journal of neurology, neurosurgery, and psychiatry.

Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease

C. V. van Duijn, P. S. Sillevis Smitt, A. Rozemuller, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Current and future approaches for treatment of paraneoplastic neurological syndromes with well-characterized onconeural antibodies

P. S. Sillevis Smitt, J. Gratama, J. van Rosmalen, 2014 .

Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies

M. J. van den Bent, P. S. Sillevis Smitt, J. Gratama, 2002, Annals of Hematology.

Quantitative matrix-assisted laser desorption ionization-fourier transform ion cyclotron resonance (MALDI-FT-ICR) peptide profiling and identification of multiple-sclerosis-related proteins.

T. Luider, R. Lamers, P. S. Sillevis Smitt, 2009, Journal of proteome research.

Three sensitive assays do not provide evidence for circulating HuD-specific T cells in the blood of patients with paraneoplastic neurological syndromes with anti-Hu antibodies.

P. S. Sillevis Smitt, C. Lamers, J. Gratama, 2012, Neuro-oncology.

From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.

P. S. Sillevis Smitt, P. Wirtz, M. Titulaer, 2016, Autoimmunity reviews.

Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics

W. Dinjens, J. Kros, P. S. Sillevis Smitt, 2014, Journal of Neuro-Oncology.

Truncating the i-leader open reading frame enhances release of human adenovirus type 5 in glioma cells

M. Lamfers, P. S. Sillevis Smitt, Taco G. Uil, 2011, Virology Journal.

Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration

J. Honnorat, P. S. Sillevis Smitt, R. Voltz, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System

C. Hoogenraad, P. S. Sillevis Smitt, E. de Graaff, 2016, Front. Mol. Neurosci..

Psychiatric phenomena as initial manifestation of encephalitis by anti‐NMDAR antibodies

C. Hoogenraad, P. S. Sillevis Smitt, R. Verdijk, 2013, Acta Neuropsychiatrica.

Low-Molecular Weight Caldesmon as a Potential Serum Marker for Glioma

W. Hop, M. J. van den Bent, T. Luider, 2005, Clinical Cancer Research.

Effector memory and late memory T cells accumulate in the blood of CMV‐carrying individuals but not in their cerebrospinal fluid

P. S. Sillevis Smitt, J. Gratama, J. Kraan, 2013, Cytometry. Part B, Clinical cytometry.

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes

C. Hoogenraad, J. Démonet, J. Verschuuren, 2017, Annals of clinical and translational neurology.

Spinal epidural abscess complicating chronic epidural analgesia in 11 cancer patients: clinical findings and magnetic resonance imaging

M. J. van den Bent, P. S. Sillevis Smitt, C. Vecht, 1999, Journal of Neurology.

Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?

S. Vukusic, J. Honnorat, C. Confavreux, 2010, Archives of neurology.

Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.

S. Nakanishi, R. Shigemoto, C. D. De Zeeuw, 2000, The New England journal of medicine.

Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis

J. Honnorat, C. Bien, M. Rosenfeld, 2020, Neurology.

Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

M. J. van den Bent, B. van der Holt, P. S. Sillevis Smitt, 2003, Brain : a journal of neurology.

Molecular and cellular mechanisms underlying anti-neuronal antibody mediated disorders of the central nervous system.

C. Hoogenraad, P. S. Sillevis Smitt, E. Graaff, 2014, Autoimmunity reviews.

Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force

J. Honnorat, R. Soffietti, N. Gilhus, 2011, European journal of neurology.

No evidence for the presence of HuD-specific T cells in the cerebrospinal fluid of patients with Huassociated paraneoplastic neurological syndromes

P. S. Sillevis Smitt, C. Lamers, J. Gratama, 2009, Journal of Neurology.

Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options

M. V. van Gisbergen, R. Yadak, P. S. Sillevis Smitt, 2017, Front. Cell. Neurosci..

Circulating glioma biomarkers.

T. Luider, J. Kros, P. S. Sillevis Smitt, 2014, Neuro-oncology.

Molecular subtypes of glioma identified by genome‐wide methylation profiling

M. J. van den Bent, P. Eilers, J. D. de Rooi, 2013, Genes, chromosomes & cancer.

Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.

M. J. van den Bent, M. Taphoorn, T. Gorlia, 2015, Neuro-oncology.

Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens

P. French, J. Kros, P. S. Sillevis Smitt, 2019, Scientific Reports.

Lack of B and T cell reactivity towards IDH1R132H in blood and tumor tissue from LGG patients

P. French, P. S. Sillevis Smitt, R. Debets, 2019, Journal of Neuro-Oncology.

Proteomics Comparison of Cerebrospinal Fluid of Relapsing Remitting and Primary Progressive Multiple Sclerosis

T. Luider, P. S. Sillevis Smitt, L. Dekker, 2010, PloS one.

The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen

Lucy F. Stead, G. Reifenberger, Erwin G. Van Meir, 2021, bioRxiv.

The use of eye‐movement recording in patients with anti‐Hu antibody–associated paraneoplastic neurological syndromes to objectively determine extent and course of disease

M. Frens, P. S. Sillevis Smitt, J. N. van der Geest, 2021, European journal of neurology.

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer

Wendy J. C. Prager-van der Smissen, M. Smid, J. Martens, 2020, Scientific Reports.

Anti-LGI1 encephalitis

E. Sánchez, P. S. Sillevis Smitt, L. Jiskoot, 2016, Neurology.

The "pain pen" for breakthrough cancer pain: a promising treatment.

P. S. Sillevis Smitt, R. Enting, W. Oldenmenger, 2005, Journal of pain and symptom management.

Mutation and drug-specific intracellular accumulation of EGFR predict clinical responses to tyrosine kinase inhibitors

J. Aerts, P. French, P. S. Sillevis Smitt, 2020, EBioMedicine.

Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.

J. G. van Dijk, A. Vincent, J. Verschuuren, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score

R. Rouhl, B. Roozenbeek, P. S. Sillevis Smitt, 2021, Annals of neurology.

The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies

C. Hoogenraad, Jeroen A. A. Demmers, J. Veldink, 2019, Brain : a journal of neurology.

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis

C. V. van Donselaar, R. Rouhl, P. S. Sillevis Smitt, 2019, Neurology.

Novel methods to diagnose leptomeningeal metastases in breast cancer

S. Sleijfer, M. J. van den Bent, A. Jager, 2018, Neuro-oncology.

Pediatric autoimmune encephalitis

P. S. Sillevis Smitt, R. Hintzen, M. Titulaer, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis

C. Catsman-Berrevoets, F. Aarsen, P. S. Sillevis Smitt, 2018, Neurology.

Autoimmune Encephalitis Resembling Dementia Syndromes

M. Verbeek, P. S. Sillevis Smitt, Frank Jan de Jong, 2021, Neurology: Neuroimmunology & Neuroinflammation.

The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies

P. S. Sillevis Smitt, R. Thijs, M. Titulaer, 2016, Neurology.

Exon Expression Arrays as a Tool to Identify New Cancer Genes

A. Hollestelle, M. Schutte, P. J. van der Spek, 2008, PloS one.

Immune Repertoire after Immunization As Seen by Next-Generation Sequencing and Proteomics

Theo M. Luider, Martijn M. VanDuijn, T. Luider, 2017, Front. Immunol..

An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions

T. Luider, P. S. Sillevis Smitt, L. Dekker, 2010, Analytical and bioanalytical chemistry.

Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features

M. J. van den Bent, W. Dinjens, L. Looijenga, 2003, Cancer.

IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis

M. Lamfers, P. French, P. S. Sillevis Smitt, 2018, PloS one.

Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas

Andrew P. Stubbs, C. Hoogenraad, M. Moorhouse, 2011, PloS one.

Progression of paclitaxel‐induced neuropathy following discontinuation of treatment

M. J. van den Bent, J. Verweij, P. S. Sillevis Smitt, 1997, Muscle & nerve.

Hela l-CaD undergoes a DNA replication-associated switch in localization from the cytoplasm to the nuclei of endothelial cells/endothelial progenitor cells in human tumor vasculature

T. Luider, J. Kros, P. S. Sillevis Smitt, 2007, Cancer biology & therapy.

Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease.

A. Hofman, P. Koudstaal, M. Breteler, 2011, Journal of proteome research.

Serum clusterin levels are not increased in presymptomatic Alzheimer's disease.

A. Hofman, P. Koudstaal, M. Breteler, 2011, Journal of proteome research.

Integrated genomic profiling identifies candidate genes implicated in glioma‐genesis and a novel LEO1‐SLC12A1 fusion gene

C. Hoogenraad, M. J. van den Bent, A. Sacchetti, 2010, Genes, chromosomes & cancer.

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.

M. J. van den Bent, W. Dinjens, T. Postma, 2011, Neuro-oncology.

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study

M. J. van den Bent, J. Kros, P. S. Sillevis Smitt, 2012, Journal of Neuro-Oncology.

Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

Dieta Brandsma, M. J. van den Bent, P. S. Sillevis Smitt, 2008, Cancer.

Gene expression profiles associated with treatment response in oligodendrogliomas.

Jord H A Nagel, Mathilde C M Kouwenhoven, Peter van der Spek, 2005, Cancer research.

A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes.

P. S. Sillevis Smitt, J. Gratama, H. Hooijkaas, 2015, Neuro-oncology.

Quantitative Proteomics and Metabolomics Analysis of Normal Human Cerebrospinal Fluid Samples*

S. Wijmenga, T. Hankemeier, L. Buydens, 2010, Molecular & Cellular Proteomics.

Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.

P. S. Sillevis Smitt, P. Wijermans, P. Ypma, 2006, The Netherlands journal of medicine.

Anti-Ri positive opsoclonus-myoclonus-ataxia in ovarian duct cancer

P. S. Sillevis Smitt, C. Vecht, C. Tijssen, 1998, Journal of Neurology.

Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases

S. Sleijfer, M. J. van den Bent, A. Jager, 2021, Clinical Cancer Research.

C. Hoogenraad, P. S. Sillevis Smitt, E. de Graaff, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Identification of Tumor‐Related Proteins by Proteomic Analysis of Cerebrospinal Fluid from Patients with Primary Brain Tumors

Rob Pieters, Ping-Pin Zheng, Theo M Luider, 2003, Journal of neuropathology and experimental neurology.

Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling.

M. D. Den Boer, R. Pieters, J. Kros, 2006, Clinical chemistry.

Label-free peptide profiling of Orbitrap™ full mass spectra

Christoph Stingl, Theo M Luider, T. Luider, 2011, BMC Research Notes.

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal.

P. S. Sillevis Smitt, G. Stoter, W. Oldenmenger, 2009, European journal of cancer.

Analgesic adherence measurement in cancer patients: comparison between electronic monitoring and diary.

M. Echteld, R. de Wit, P. S. Sillevis Smitt, 2007, Journal of pain and symptom management.

Multiple sclerosis‐related proteins identified in cerebrospinal fluid by advanced mass spectrometry

T. Luider, P. S. Sillevis Smitt, L. Dekker, 2008, Proteomics.

Eye movements as a marker for cerebellar damage in paraneoplastic neurological syndromes.

M. Frens, P. S. Sillevis Smitt, J. N. van der Geest, 2007, Parkinsonism & related disorders.

Comparative study of targeted and label-free mass spectrometry methods for protein quantification.

T. Luider, P. S. Sillevis Smitt, L. Dekker, 2013, Journal of proteome research.

A new method to analyze matrix-assisted laser desorption/ionization time-of-flight peptide profiling mass spectra.

Guido Jenster, Ivar Siccama, Theo M Luider, 2005, Rapid communications in mass spectrometry : RCM.

A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids

P. S. Sillevis Smitt, E. Wilms, R. Enting, 2002, Cancer.

Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data

P. Eilers, P. French, P. S. Sillevis Smitt, 2022, iScience.

Serum proteomics in amnestic mild cognitive impairment

N. Prins, P. Koudstaal, T. Luider, 2013, Proteomics.

Circulating glioma biomarkers.

T. Luider, J. Kros, P. S. Sillevis Smitt, 2014, Neuro-oncology.

Mimics of Autoimmune Encephalitis

P. S. Sillevis Smitt, R. Verdijk, M. Gardeniers, 2023, Neurology: Neuroimmunology & Neuroinflammation.

Abstract 808: Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology

Andrew P. Stubbs, B. De Moor, M. J. van den Bent, 2010 .

Serum proteomics in amnestic mild cognitive impairment

N. Prins, P. Koudstaal, T. Luider, 2013, Proteomics.

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal.

P. S. Sillevis Smitt, G. Stoter, W. Oldenmenger, 2009, European journal of cancer.

Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma

M. J. van den Bent, T. Luider, J. Kros, 2007, Electrophoresis.